Lymphadenopathy: Evaluation and Differential Diagnosis

Area of Science:

• Medical diagnostics
• Clinical medicine
• Pathology

Background:

• Lymphadenopathy affects 0.6% of the population annually, with most cases being benign.
• A thorough patient history and physical examination are crucial for initial assessment.
• Differentiating localized from generalized lymphadenopathy is key, as generalized forms often indicate systemic disease.

Purpose of the Study:

• To outline the diagnostic approach for lymphadenopathy.
• To highlight key historical and physical examination findings.
• To guide the selection of appropriate investigations and treatments.

Main Methods:

• Detailed patient history focusing on lymph node characteristics, symptoms, exposures, and medical history.
• Physical examination to distinguish localized versus generalized lymphadenopathy and assess node characteristics (size, consistency, mobility).
• Guidance on further investigations including imaging, laboratory tests (CBC, CRP, ESR, TB testing), and biopsy techniques (FNA, core, excisional).

Main Results:

• Localized lymphadenopathy can indicate infection or malignancy, especially when epitrochlear or supraclavicular nodes are involved.
• Enlarged (>2 cm), hard, or matted lymph nodes may suggest malignancy or granulomatous diseases, particularly in children.
• Persistent lymphadenopathy (>4 weeks) or lymphadenopathy with systemic symptoms warrants further investigation.

Conclusions:

• A systematic approach combining history, physical exam, and targeted investigations is essential for managing lymphadenopathy.
• Biopsy is a definitive diagnostic tool when malignancy or granulomatous disease is suspected.
• Corticosteroids should be used cautiously as they can obscure diagnoses like lymphoma.